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testosterone and dehydroepiandrosterone were elevated. 
Androgens remained unchanged after adrenocorticotropic 
hormone, and dexamethasone administrations. Ultrasound 
examination and magnetic resonance imaging indicated an 
extra-adrenal mass adjacent to the left adrenal gland, which 
was removed by endoscopic surgery. However, plasma an-
drogens remained elevated and  131 I-iodomethyl-norcholes-
terol scintigraphy revealed tracer enhancement in the right 
adrenal gland, which was consecutively removed. Viriliza-
tion regressed after extirpation of the adenomas and height 
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 Abstract 
 Background: Adenomas of the adrenal gland are rare causes 
of virilization in childhood.  Case Report: A girl aged 2 years 
and 4 months presented with pubarche, distinct clitoral hy-
pertrophy, tall stature, and increased height velocity. Plasma 
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Established Facts
 • Adenomas of the adrenal gland are rare causes of virilization in childhood and are rarely located as 
bilateral or ectopic. 
 Novel Insights 
 • The presented case describes for the first time that virilization in a young girl is due to concomitant 
ectopic and intra-adrenal adenomas of the adrenal cortex. Melanocortin 2 receptor expression con-
firmed that the ectopic adenoma originated from the adrenal cortex. 
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velocity normalized.  Results: Histology revealed a circum-
scribed adenoma in the right adrenal gland and an epithe-
lial mass with adrenal cortical cells in the left-sided ectopic 
tumor. In the ectopic tumor, melanocortin 2 receptor ex-
pression was augmented threefold compared to the con-
trol, indicating adrenal origin.  Conclusions: In this young 
girl, virilization is due to concomitant ectopic and intra- 
adrenal adenomas of the adrenal cortex. By melanocortin 
2 receptor expression, it was confirmed that the ectopic 
 adenoma derived from the adrenal cortex. Specific scintig-
raphy, if available, assists in allocating the source of andro-
gen hypersecretion.  Copyright © 2013 S. Karger AG, Basel 
 Introduction 
 Adrenocortical tumors (ACT) are rare in children. The 
worldwide annual incidence ranges from 0.3 to 0.38 per 
million children below the age of 15 years, with 65% oc-
currence in children younger than 5 years  [1, 2] . In young 
children, the incidence of ACT seems to be higher for 
young girls with a female/male ratio of 2: 1, whereas in ado-
lescents, the female/male ratio is 1: 1  [3–5] . In contrast to 
adults, the most frequent presentation in children with 
ACT is virilization, followed by hypercortisolism and hy-
peraldosteronism  [6, 7] . The diagnosis is supported when 
serum levels of dehydroepiandrosterone (DHEA), DHEA 
sulfate, androstenedione, and testosterone are elevated. 
The localization of the rather small tumors may be  difficult, 
especially by abdominal ultrasound. These extremely rare 
tumors are exceptionally located bilateral or ectopic, but 
to our knowledge no concomitant ectopic bilateral adre-
nal adenomas causing virilization in children are de-
scribed in the literature  [8, 9] . To verify that the ectopic 
lesion is from adrenal origin detecting the expression of 
the melanocortin 2 (MC2) receptor could be useful  [10] . 
Here, we report a young girl with concomitant ectopic and 
intra-adrenal adenomas of the adrenal cortex diagnosed 
by  131 I-iodomethylnorcholesterol scintigraphy.
 Case Report 
 At the age of 2 years and 4 months the girl was referred for 
evaluating premature pubarche. Her parents had recognized pu-
bic hair 5 months ago. She presented with pubertal stages accord-
ing to Tanner breast 1, pubic hair 3, and distinct clitoral hypertro-
phy, no acne, no axillary hair, and no striae  [11] . The girl was tall 
(102 cm; SDS +2.94) and her height velocity was increased (10.7 
cm/years; SDS 1.98) ( fig. 1 ). Biochemical assessment revealed nor-
mal serum electrolytes. Basal morning plasma concentrations of 
17-hydroxyprogesterone 3.12 nmol/l (reference range 0.09–2.73), 
androstenedione 4.6 nmol/l (reference range 0.17–1.75), testoster-
one 7.08 nmol/l (reference range <0.69), DHEA 9.4 nmol/l (refer-
ence range 0.69–4.51), and DHEA sulfate 0.34 μmol/l (reference 
range <0.052) were notably elevated. The urinary steroid metabo-
lome revealed a 2.5-fold elevated excretion rates of androgen me-
tabolites, such as androsterone, etiocholanolone, 16-alpha-hydro-
xy-DHEA, 5-androstene-3β,17β-diol, 3β,16α,17β-androstenetriol, 
11-OH-androsterone, and testosterone. Glucocorticosteroid ex-
cretion in 24-hour urine, circadian adrenocorticotropic hormone 
(ACTH), and cortisol were not elevated. The bone age (Greulich 
and Pyle) was accelerated to 4 2/12 years  [12] . Initially, we pre-
sumed that the underlying disease was 21-hydroxylase-deficiency 
or other forms of virilizing congenital adrenal hyperplasia, but fi-
nally this hypothesis was excluded by ACTH test, molecular ge-
netic analysis, and urinary steroid metabolomics analysis. 
 As part of the clinical work-up, abdominal ultrasound was 
performed, which revealed a slightly thickened right adrenal 
gland, while the left adrenal gland was normal. In contrast, MRI 
revealed an ectopic tumor in the area of the left renal hilus with a 
diameter of 13 mm. Surgical excision of this ectopic lesion dis-
closed a beige tumor measuring 1.8 × 1 × 0.8 cm. However, de-
 Fig. 1. Growth chart of the patient.  Arrows indicate the two 
s equential operations. 
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spite the complete excision of the ectopic tumor located in the left 
renal hilus, testosterone and DHEA decreased approximately by 
50%, but were still elevated: 2.88 nmol/l (reference range <0.69) 
and 6.32 nmol/l (reference range 0.69–4.51), respectively. After 
oral application of 1 mg dexamethasone plasma testosterone and 
DHEA were not suppressed, 1.77 nmol/l (age-adjusted female 
range <0.69) and 33.17 nmol/l (reference range 0.69–4.51), re-
spectively. Abdominal ultrasound demonstrated again a slightly 
enlarged right adrenal gland and for specification  131 I-iodome-
thylnorcholesterol scintigraphy was performed after administra-
tion of 1 mg dexamethasone and sodium perchlorate. Enhance-
ment of the tracer was clearly detectable in the right gland and 
total adrenalectomy of the right gland was performed. Histologi-
cal examination revealed a 0.4 × 0.6 cm tumor located paracen-
trally and reaching the mark of the adrenal gland. Subsequently, 
virilization regressed after removal of these two adenomas and 
height velocity normalized to 6.79 cm/year (SDS –0.96). Testos-
terone and DHEA decreased to the normal infantile range, 0.17 
and 0.83 nmol/l, respectively. Because bilateral adrenal adenomas 
could be associated with McCune-Albright syndrome, we exclud-
ed this disease pattern clinically in our patient.
 Methods 
 Serum steroid hormones were determined by radioimmuno-
assays using tritiated steroids (Amersham Biosciences, Freiburg, 
Germany) and specific antibodies, raised and characterized in the 
steroid laboratory, as described elsewhere  [13] . The urinary ste-
roid metabolome was assessed by gas chromatography-mass 
spectrometry  [14] . 
 RNA was extracted from the ectopic tumor in the area of the 
left adrenal gland (QIAGEN, Hilden, Germany). MC2 receptor 
and LH receptor mRNA expression were investigated by quantita-
tive PCR according to Zwermann et al.  [10] .
 The patient’s parents were informed about all the diagnostic 
procedures and gave their written consent for the necessary sur-
gery, tumor removal, and analysis of tumor tissue.
 Results 
 Histological examination of the ectopic lesion close 
to the left renal hilus revealed an oxyphilic epithelial tu-
mor with a Ki67 proliferation index ranging from 2 to 
5%. Staining was positive for synaptophysin, melan-A, in-
hibin, and CD56, weak staining for calretinin. β-human 
chorionic gonadotropin hormone, alpha-1-fetoprotein, 
placental alkaline phosphatase, protein S100, and chro-
mogranin A were not detectable. In the ectopic tumor 
MC2R expression was threefold higher in comparison to 
normal adrenal glands while only low expression of the 
LH receptor was detected in comparison to normal adre-
nals ( fig. 2 ). The intra-adrenal tumor of the right adrenal 
gland contained oxyphilic epithelial cells with a Ki67 pro-
liferation index of 2–5% and no invasion of the capsula or 
vessels were detected. Further immunohistochemical in-
vestigation demonstrated positive staining for synapto-
physin, vimentin, melan-A, inhibin and CD56, while pan-
zytokeratin (KL-1), calretinin, CD 31, protein S100 and 
chromogranin A were not detectable.
 Discussion 
 We herein describe a young girl who presented with 
precocious pseudopuberty caused by concomitant ecto-
pic and intra-adrenal adenomas of the adrenal cortex. 
Initially, we supposed that adrenal congenital hyperpla-
sia was the underlying disease. Finally, this clinical pic-
ture was excluded and we presumed an adrenal tumor is 
causing virilization. Clinical signs of virilizing adrenal 
tumors in children include precocious pubic hair, hyper-
trophy of the penis or clitoris, acne, gynecomastia, in-
creased height velocity, and accelerated bone age. Diag-
nosis is supported by measuring plasma DHEA, DHEA 
sulfate, androstenedione, testosterone, 17OHP, and uri-
nary steroids  [15–18] . In addition, these hormones are 
also helpful as follow-up markers for detection of recur-
rence of the disease until puberty. The preoperative man-
datory precise location of the tumors in the case of small 
lesions can present as a particular clinical challenge. In 
the presented case initial abdominal ultrasound investi-
gations failed to detect the tumor. Furthermore, during 
the initial abdominal MRI only the ectopic tumor in the 
left renal hilus was visualized, while the procedure failed 
to detect the small nodule in the right adrenal gland. But 
after extirpation of the ectopic tumor of the left adrenal 
gland hyperandrogenism persisted. Because using con-
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 Fig. 2. Expression of mRNA (-fold) of MC2 receptor and LH 
 receptor by PCR. 
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ventional imaging techniques localization of the second 
tumor was not successful,  131 I-iodomethylnorcholesterol 
scintigraphy was performed. This method has been re-
ported to provide a higher sensitivity in localizing ste-
roid-secreting lesions in comparison to MRI and corre-
lates well with steroid biosynthesis  [19] . However, the 
tracer is associated with a substantial radiation dosage 
and experiences in children are limited. In most Euro-
pean countries the production of the tracer has been ter-
minated  [20] . Recently,  123 I- iodometomidate was used as 
a highly specific radiotracer for imaging of adrenocorti-
cal tissue  [21] . Till now no publications are available in 
which this radiotracer was used in children. We believe 
therefore that the use of scintigraphy should be restricted 
to the rare cases in which the conventional diagnostic 
strategies failed.  Prediagnostic treatment with dexa-
methasone is recommended in order to suppress the reg-
ular adrenal glands. Overall, our patient had concomi-
tant intra-adrenal as well as ectopic adenomas of adrenal 
origin. Usually, hormone-secreting adenomas which are 
located bilaterally produce cortisol  [22] , bilateral ACT 
secreting androgens are extremely rare  [23] . Uncom-
monly, ectopic adrenal tissue can become clinically ap-
parent. To our knowledge, only 2 cases of an ectopic cor-
tical adrenal mass in the thorax and behind the iliopsoas 
muscle, producing strictly androgens, have been report-
ed in adults  [8, 9] . Louiset et al.  [24] described an ACTH-
independent Cushing´s syndrome with bilateral mi-
cronodular adrenal hyperplasia and ectopic adrenocor-
tical adenoma. But the combination of ectopic and 
intra-adrenal adenoma-secreting androgens is not de-
scribed until now. In our patient, both adenomas dem-
onstrate common histological features. To verify that the 
ectopic tumor was of adrenal origin, we checked the ex-
pression of MC2R, which was readily detectable by real-
time PCR. Interestingly, no suppression of androgens 
was observable after dexamethasone administration, de-
spite the high expression of MC2R indicating autono-
mous activation of steroidogenesis. Because both tumors 
demonstrated the identical histological picture and an-
drogens decreased half after the first operation we could 
speculate that both tumor parts contribute equally to the 
androgen secretion.
 Ectopic adrenal tissue is estimated to occur in about 
1% of the adult population and up to 50% in neonates. 
Usually, ectopic adrenal tissue regresses in early infancy 
 [25] . The adrenal cortex develops from the coelomic me-
soderm of the urogenital ridge during the 5th week of 
gestational age and separates from it during the 8th week 
 [26, 27] . Ectopic adrenal tissue occurs when a fragment of 
the primitive adrenal gland sheds off during develop-
ment. It may rest in any visceral organ, more frequently 
in the kidney, liver, and gonads. Ectopic adrenal tissue 
may contain both cortex and medulla, if the breaking 
event occurs after migration of neural crest tissue into the 
cortex. 
 Assessing the malignant potential of adrenal tumors 
solely on the basis of pathological examination can prove 
to be difficult. Tumor weight and size, signs of vascular 
invasion and a high mitotic index are morphological 
signs of tumor carcinogenic potential. A tumor weight 
more than 100 g and a diameter greater than 5 cm are in-
dicators of malignancy and infiltration of the surround-
ing tissue or presence of metastases are obvious signs for 
carcinoma  [17, 28, 29] . In uncertain cases, even estab-
lished histopathological criteria and algorithms adapted 
from tumors in adults generally do not allow clear clas-
sification in children  [29–31] .
 Recently, molecular and genetic markers have been as-
sessed for their potential to differentiate adrenocortical 
carcinomas from benign adenomas  [30–37] . In our pa-
tient, analysis of steroid hormones revealed only hyper-
androgenism. Generally, adrenal cortical carcinomas 
presents more commonly as a mixed Cushing-virilizing 
syndrome  [38] . Histology investigation of both adeno-
mas demonstrated Ki67 proliferation index of 2–5% and 
no invasion of the capsula or vessels were detected. The 
analysis of the steroid hormones and the histological eval-
uation led us assume, that in our case the tumor has no 
malignant potential, but prolonged and vigilant follow up 
is absolutely necessary.
 The treatment of choice for adrenal lesions with au-
tonomous steroid secretion or signs indicative of malig-
nancy is radical resection of the complete tumor by open 
abdominal or laparoscopic surgery. Long-term follow-up 
is advisable for detecting recurrence of the disease.
 Our findings underline that androgen-producing ad-
enomas may be located within and/or outside the adrenal 
cortex, and may provoke severe virilization in prepuber-
tal girls. MC2 receptor expression in the tumor indicates 
the adrenal cortex’s descent. Specific functional imaging, 
if available, can assist in allocating the source of andro-
gen hypersecretion. Long-term follow-up is warranted to 
assure complete removal of the adenomas.
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